Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human Placenta-Derived Adherent Cells Prevent Bone loss, Stimulate Bone formation, and Suppress Growth of Multiple Myeloma in Bone

23 Nov 2010

Abstract excerpt

Human placenta has emerged as a valuable source of transplantable cells of mesenchymal and hematopoietic origin for multiple cytotherapeutic purposes, including enhanced engraftment of hematopoietic stem cells, modulation of inflammation, bone repair, and cancer. Placenta-derived adherent cells (PDACs) are mesenchymal-like stem cells isolated from postpartum human placenta. Multiple myeloma is closely associated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone health and treatments
Share to Bone Metabolism and Diseases
Share to Mesenchymal stem cell research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21732484
DOI: 10.1002/stem.572

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 11 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human Placenta-Derived Adherent Cells Prevent Bone loss, Stimulate Bone formation, and Suppress Growth of Multiple Myeloma in BonePMID 21732484Read ↗

Osteoblast suppression in multiple myeloma bone diseaseSemantic proximity Read ↗

Contact of myeloma cells induces a characteristic transcriptome signature in skeletal precursor cells -Implications for myeloma bone disease.Semantic proximity Read ↗

Epigenetic‐Based Mechanisms of Osteoblast Suppression in Multiple Myeloma Bone DiseaseSemantic proximity Read ↗

Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients.Semantic proximity Read ↗

Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patientsSemantic proximity Read ↗

Myeloma impairs mature osteoblast function but causes early expansion of osteo‐progenitors: temporal changes in bone physiology and gene expression in the KMS12BM modelSemantic proximity Read ↗

Bone morphogenetic protein 4 gene therapy in mice inhibits myeloma tumor growth, but has a negative impact on boneSemantic proximity Read ↗

Reprogrammed marrow adipocytes contribute to myeloma-induced bone diseaseSemantic proximity Read ↗

Dynamic interplay between bone and multiple myeloma: Emerging roles of the osteoblastSemantic proximity Read ↗

Romosozumab Safely Restores Bone Mass in Multiple Myeloma via Osteoblast Reprogramming: A Phase IIa StudySemantic proximity Read ↗

pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivoSemantic proximity Read ↗

A detailed methodology for developing and applying a 3D polyHIPE scaffold to model myeloma cell dormancy in vitroSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.